Cannabis Regulation In Australia Could Be About To Become Way Less Complex

Cannabis regulation in Australia has taken a step forward. Last Thursday, a report into the Narcotic Drugs Act (ND Act) was tabled in Parliament, which recommended a major overhaul of the licensing regime for the drug and might see more Australian businesses able to operate in the growing market. Read more

California Wheat Biotech Firm Expands Hemp Investment With $10 Million Raise

An agriculture biotech company that markets high-fiber wheat said it is expanding its hemp subsidiary with a $10 million stock offering. Arcadia Biosciences of Davis, California, plans to use the money to research hemp genetics in Imperial County, California, according to a news release. The company’s hemp subsidiary, Arcadia Specialty Genomics, is scheduled to start planting hemp there Oct. 1. Read more

US Government Funds $3M In Research On CBD Pain Relief

The U.S. government is set to find out, as it will spend $3 million on scientific research of the compound, according to The Associated Press. The National Center for Complementary and Integrative Health announced Thursday nine research grants to research “the potential pain-relieving properties and mechanisms of actions of the diverse phytochemicals in cannabis, including both minor cannabinoids and terpene.” Read more

Is Hemp a Safer Way to Invest in the Cannabis Industry?

Profits have been elusive for many companies in the cannabis industry. With federal law making it impossible for companies to expand their operations across the U.S without either acquiring a company in another state or setting up an entirely new operation, it’s been very difficult for costs to stay at manageable levels. The one workaround, however, has been for companies like Charlotte’s Web that have chosen a different route: hemp. Read more

USDA Submits Draft Hemp Rules to White House

The U.S. Department of Agriculture has submitted its hemp regulations to the White House Office of Management and Budget for approval, according to a UPI report. The rules are expected to designate hemp as a commodity crop and allow tribal councils and U.S. territories to cultivate hemp crops. Read more

Kansas Hemp Growers Experiencing Struggles, Successes In First Year

The newest crop in Kansas is bringing mixed results for farmers. 2019 is the first year people in Kansas are allowed to grow hemp. “Consistently lot of farmers having trouble getting growing to start,” said James DeWitt, co-founder of United American Hemp in Olathe. Read more

Wall Street’s First Cannabis Analyst Names Her Top US Marijuana Stocks

Top Cowen analyst Vivien Azer started covering the main cannabis players in 2016, about two years before Canada even legalized adult recreational use. Needless to say, for cannabis investors trying to make sense of a rapidly maturing space, her insights are those that catch significant attention. Read more

This Is the First Hemp Strain to Be Awarded a US Patent

As the high-CBD strain that won over skeptics and helped change the national conversation around medical marijuana, Charlotte’s Web may be one of the most famous cannabis strains in the world. Read more

FTC Eyes More Aggressive Action Against CBD Disease Claims

But in an interview with Natural Products INSIDER, an FTC official suggested the agency will take more forceful enforcement action in the future against marketers who advertise CBD as a treatment for serious diseases without the science to substantiate their advertising claims. Read more

Hemp Is Back In Chile, And The Market Is Ready For Investment

Barbara Galletti is co-founder and CEO of Pronatura Ltda., and co-creator of Nutranabis, the first Chilean brand exclusively dedicated to the re-introduction and commercialization of organic hemp products in Chile. Galletti’s work has been crucial in opening Chile’s hemp market by regularizing the process for import and sales of hemp products. Galletti will be a speaker at the Latin American and Caribbean Hemp Summit, Montevideo, Uruguay Nov 8-9, 2019. Read more

UK Company Set To Be Largest Cannabis Company On London Stock Market

Cannaray, a British medical cannabis company, closed last Monday with a £7.8m (~€8.8m) Series A Funding round and hopes to raise more than £30m in the coming year in the hope of floating the £100m value. Read more